Examination of CD302 as a potential therapeutic target for acute myeloid leukemia.

Examination of CD302 as a potential therapeutic target for acute myeloid leukemia.

Acute myeloid leukemia (AML) is the most common form of adult acute leukemia with ~20,000 new cases yearly. The disease develops in people of all ages, but is more prominent in the elderly, who due to limited treatment options, have poor overall survival rates. Monoclonal antibodies (mAb) targeting...

Full description

Bibliographic Details
Main Authors: Tsun-Ho Lo, Edward Abadir, Robin E Gasiorowski, Karieshma Kabani, Murari Ramesh, Daniel Orellana, Phillip D Fromm, Fiona Kupresanin, Elizabeth Newman, Ilona Cunningham, Derek N J Hart, Pablo A Silveira, Georgina J Clark
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0216368

Internet

https://doi.org/10.1371/journal.pone.0216368

Similar Items